• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

树突状细胞中吲哚胺 2,3-双加氧酶 1 的表达降低导致免疫性血小板减少症中调节性 T 细胞发育受损。

Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.

机构信息

Institute of Hematology, Department of Hematology and Oncological Sciences L. e A. Seràgnoli, University of Bologna, Bologna, Italy.

出版信息

Ann Hematol. 2013 Jan;92(1):67-78. doi: 10.1007/s00277-012-1556-5. Epub 2012 Aug 31.

DOI:10.1007/s00277-012-1556-5
PMID:22936460
Abstract

Along with their immunogenic role, dendritic cells (DCs) are also critical in maintaining tolerance to self-antigens by inducing regulatory T cells (Tregs) via the expression of the immunomodulatory enzyme indoleamine 2,3-dioxygenase 1 (IDO1). In turn, Tregs modulate the maturation and/or function of DCs. In immune thrombocytopenia (ITP), the interaction between DCs and Tregs has never been investigated although decreased number/function of Tregs as well as altered DCs have been described. Here, we ask whether, in ITP: (1) IDO1 expression/activity is decreased in mature DCs; (2) IDO1-mediated Treg generation is impaired; and (3) DC maturation is abnormally modulated by Tregs. We found that in ITP, DCs show reduced capability of upregulating the expression/activity of IDO1. This finding results in the reduced ability of mature DCs of converting T cells into Tregs. In turn, Tregs are characterized by decreased interleukin-10 production and show lower ability of inhibiting DC maturation. In conclusion, these data point out the role of IDO1 in the impaired regulatory T cell development of ITP patients and suggest that the cross-talk between Tregs and DCs is hampered and plays a pathogenetic role.

摘要

树突状细胞(DCs)除了具有免疫原性作用外,还通过表达免疫调节酶吲哚胺 2,3-双加氧酶 1(IDO1)诱导调节性 T 细胞(Tregs),从而在维持对自身抗原的耐受方面也起着至关重要的作用。反过来,Tregs 调节 DCs 的成熟和/或功能。在免疫性血小板减少症(ITP)中,尽管已经描述了 Tregs 的数量/功能减少以及 DCs 的改变,但 DCs 和 Tregs 之间的相互作用从未被研究过。在这里,我们询问在 ITP 中:(1)成熟 DCs 中 IDO1 的表达/活性是否降低;(2)IDO1 介导的 Treg 生成是否受损;以及(3)Tregs 是否异常调节 DC 成熟。我们发现,在 ITP 中,DCs 上调 IDO1 的表达/活性的能力降低。这一发现导致成熟 DC 转化 T 细胞为 Treg 的能力降低。反过来,Tregs 的白细胞介素-10 产生减少,并且抑制 DC 成熟的能力降低。总之,这些数据指出了 IDO1 在 ITP 患者调节性 T 细胞发育受损中的作用,并表明 Tregs 和 DCs 之间的相互作用受阻,并发挥了致病作用。

相似文献

1
Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.树突状细胞中吲哚胺 2,3-双加氧酶 1 的表达降低导致免疫性血小板减少症中调节性 T 细胞发育受损。
Ann Hematol. 2013 Jan;92(1):67-78. doi: 10.1007/s00277-012-1556-5. Epub 2012 Aug 31.
2
Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia.树突状细胞中吲哚胺 2,3-双加氧酶表达降低及其在免疫性血小板减少症中的作用。
Ann Hematol. 2012 Oct;91(10):1623-31. doi: 10.1007/s00277-012-1451-0. Epub 2012 Apr 13.
3
Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.印苦楝叶糖蛋白通过减轻宫颈癌 IIIB 期患者过度活跃的调节性 T 细胞,克服树突状细胞中吲哚胺 2,3 双加氧酶介导的耐受。
Hum Immunol. 2013 Aug;74(8):1015-23. doi: 10.1016/j.humimm.2013.04.022. Epub 2013 Apr 27.
4
PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response.PGE2 诱导的 IDO1 抑制完全成熟的 DC 诱导体外抗白血病免疫反应的能力。
J Immunol Res. 2015;2015:253191. doi: 10.1155/2015/253191. Epub 2015 Feb 26.
5
CD70-silenced dendritic cells induce immune tolerance in immune thrombocytopenia patients.沉默 CD70 的树突状细胞可诱导免疫性血小板减少症患者免疫耐受。
Br J Haematol. 2020 Nov;191(3):466-475. doi: 10.1111/bjh.16689. Epub 2020 May 18.
6
Up-regulated expression of indoleamine 2,3-dioxygenase 1 in non-Hodgkin lymphoma correlates with increased regulatory T-cell infiltration.非霍奇金淋巴瘤中吲哚胺2,3-双加氧酶1表达上调与调节性T细胞浸润增加相关。
Leuk Lymphoma. 2014 Feb;55(2):405-14. doi: 10.3109/10428194.2013.804917. Epub 2013 Jun 26.
7
Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.半乳糖凝集素 3 通过促进 TLR-2 依赖的 IDO1/犬尿氨酸途径在肾脏 DC 中的激活来防止顺铂诱导的急性肾损伤。
Theranostics. 2019 Aug 14;9(20):5976-6001. doi: 10.7150/thno.33959. eCollection 2019.
8
LPS enhances CTB-INSULIN induction of IDO1 and IL-10 synthesis in human dendritic cells.脂多糖增强 CTB-INSULIN 诱导人树突状细胞中 IDO1 和 IL-10 的合成。
Cell Immunol. 2019 Apr;338:32-42. doi: 10.1016/j.cellimm.2019.03.003. Epub 2019 Mar 19.
9
Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.表达吲哚胺2,3-双加氧酶的成熟人单核细胞衍生树突状细胞可扩增高效的自体调节性T细胞。
Blood. 2009 Jul 16;114(3):555-63. doi: 10.1182/blood-2008-11-191197. Epub 2009 May 22.
10
The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells.SOCS3 非依赖性的 IDO2 表达可支持人树突状细胞中 T 调节细胞的稳态生成。
J Immunol. 2014 Feb 1;192(3):1231-40. doi: 10.4049/jimmunol.1300720. Epub 2014 Jan 3.

引用本文的文献

1
Effects of Trichinella spiralis excretory-secretory antigens on expression of indoleamine 2, 3-dioxygenase on dendritic cells in vitro.旋毛虫排泄分泌抗原对树突状细胞吲哚胺2,3-双加氧酶体外表达的影响
Parasite. 2025;32:26. doi: 10.1051/parasite/2025018. Epub 2025 Apr 16.
2
Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations.调节性 T 细胞:免疫平衡的掌控者和未来治疗创新的源泉。
Front Immunol. 2024 Sep 3;15:1457189. doi: 10.3389/fimmu.2024.1457189. eCollection 2024.
3
High dimensional proteomic mapping of bone marrow immune characteristics in immune thrombocytopenia.
免疫性血小板减少症骨髓免疫特征的高维蛋白质组学图谱。
Sci China Life Sci. 2024 Aug;67(8):1635-1647. doi: 10.1007/s11427-023-2520-4. Epub 2024 Apr 19.
4
Pathogenesis of refractory ITP: Overview.难治性 ITP 的发病机制:概述。
Br J Haematol. 2023 Oct;203(1):10-16. doi: 10.1111/bjh.19083.
5
How we treat primary immune thrombocytopenia in adults.成人原发免疫性血小板减少症的治疗方法。
J Hematol Oncol. 2023 Jan 19;16(1):4. doi: 10.1186/s13045-023-01401-z.
6
Immune Thrombocytopenic Purpura as a Hemorrhagic Versus Thrombotic Disease: An Updated Insight into Pathophysiological Mechanisms.免疫性血小板减少性紫癜:一种出血性与血栓性疾病——对病理生理机制的最新认识。
Medicina (Kaunas). 2022 Feb 1;58(2):211. doi: 10.3390/medicina58020211.
7
[Prospects of individualized diagnosis and treatment of primary immune thrombocytopenia in the era of new drugs].[新药时代原发性免疫性血小板减少症的个体化诊断与治疗前景]
Zhonghua Xue Ye Xue Za Zhi. 2021 Nov 14;42(11):965-968. doi: 10.3760/cma.j.issn.0253-2727.2021.11.017.
8
Monocytes complexed to platelets differentiate into functionally deficient dendritic cells.血小板黏附的单核细胞分化为功能缺陷的树突状细胞。
J Leukoc Biol. 2021 Apr;109(4):807-820. doi: 10.1002/JLB.3A0620-460RR. Epub 2020 Jul 14.
9
[Effect and mechanism of low-dose chidamide on the treatment of primary immune thrombocytopenia].低剂量西达本胺治疗原发性免疫性血小板减少症的疗效及机制
Zhonghua Xue Ye Xue Za Zhi. 2020 Apr 14;41(4):292-296. doi: 10.3760/cma.j.issn.0253-2727.2020.04.006.
10
Emerging Concepts in Immune Thrombocytopenia.免疫性血小板减少症的新观点。
Front Immunol. 2018 Apr 30;9:880. doi: 10.3389/fimmu.2018.00880. eCollection 2018.